Crossmark

Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin pathway

Crossref DOI link: https://doi.org/10.1007/s00210-018-1552-y

Published Online: 2018-08-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmed, Hebatalla I. https://orcid.org/0000-0001-8634-6210
Abdel-Sattar, Somaia A.

Zaky, Heba S.
License Information

Text and Data Mining valid from 2018-08-06
More Information

Article History

Received: 16 April 2018

Accepted: 31 July 2018

First Online: 6 August 2018

Compliance with ethical standards

: The study was conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publications No. 8023, revised 1978) and is approved by the Ethics Committee of Faculty of Pharmacy, (Girls), Al-Azhar University.

: The authors declare that they have no conflict of interest.

: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.